Good Morning Readers,
Welcome to round two of Power Week! Yesterday’s stellar performance by Indaptus Therapeutics was just the beginning. Today, we’re thrilled to highlight Silo Pharma, Inc. (Nasdaq: SILO), a previous winner that continues to impress with groundbreaking developments. Silo just
announced positive results from their recent study on depression treatment, showcasing a potentially game-changing drug formulation. With a year-to-date return of +40.97% and analysts setting a price target of $10.00, this company has a potential 392% upside from yesterday’s close of $2.03. As Power Week heats up, let’s dive into why Silo Pharma is a
standout pick! (1)(2)(3)(4)(5)
🔑 Key Developments:
📊 Breakthrough Results: Silo’s study revealed a new drug formulation that significantly improves mood stability in depression patients, without the common side effects of current treatments.(2)
💼 Strong Pipeline: Silo is advancing its SPC-15 program for PTSD to the clinic and preparing to submit a pre-IND application to the FDA.(2)
💡 Positive Forecast: The stock holds positive signals from both
short and long-term moving averages, indicating strong future performance.(4)
📊 Analyst Target: One analyst has a positive outlook with a price target of $10.00, reflecting a potential 392% upside from yesterday’s close. (1)(4)(5)
🏍️ Solid Performance: With a YTD return of +40.97%, Silo is already showing strong momentum. (1)(5)
With a winning combination of groundbreaking achievements, solid financials, and strong leadership, Silo Pharma, Inc. (Nasdaq: SILO) is one company you will
definitely want to keep a close eye on. 👀 👀
Keep watching as Power Week continues to deliver explosive updates and incredible opportunities. Think of this as an early 4th of July celebration with more fireworks to come!
To your success,
Max Masters
Co-founder, Market Tips Newsletter
